ExPEC9V
![Sanofi Invests $175M in J&J's Advanced E. coli Vaccine, Amplifying its Vaccine Development Efforts](https://pharmtales.com/wp-content/uploads/2023/10/Sanofi-Invests-175M-in-JJs-Advanced-E.-coli-Vaccine-Amplifying-its-Vaccine-Development-Efforts.jpg)
Sanofi Invests $175M in J&J’s Advanced E. coli Vaccine, Amplifying its Vaccine Development Efforts
Anika Sharma
Sanofi is making a strategic move by investing $175 million in Johnson & Johnson’s late-phase E. coli vaccine, ExPEC9V. As ...